Form 4 Tracker
Mark L. Jacobson

Chief Operating Officer · 4 filings · Latest: May 4, 2026

Axsome Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AXSM
Mark L. JacobsonChief Operating OfficerMay 5, 2026
Sale
$228.18233$53.2K0
AXSM
Mark L. JacobsonChief Operating OfficerMay 5, 2026
Option Exercise
$12.95233$3.0K233
AXSM
Mark L. JacobsonChief Operating OfficerMay 4, 2026
Sale
$227.944,517$1.0M0
AXSM
Mark L. JacobsonChief Operating OfficerMay 4, 2026
Option Exercise
$12.954,517$58.5K4,517
AXSM
Mark JacobsonMay 5, 2026
Proposed Sale
$223.06233$52.0K
AXSM
Mark JacobsonMay 4, 2026
Proposed Sale
$223.704,517$1.0M
AXSM
Mark JacobsonMay 4, 2026
Proposed Sale
$223.704,517$1.0M
AXSM
Mark L. JacobsonChief Operating OfficerFeb 26, 2026
Sale
$161.8835,378$5.7M0
AXSM
Mark L. JacobsonChief Operating OfficerFeb 26, 2026
Option Exercise
$2.8535,378$100.8K35,378
AXSM
Mark JacobsonFeb 26, 2026
Proposed Sale
$163.1935,378$5.8M
AXSM
Jacobson Mark L.Sep 22, 2025
Proposed Sale
$115.9610,000$1.2M
AXSM
Jacobson Mark L.Sep 16, 2025
Proposed Sale
$114.4845,783$5.2M
AXSM
Jacobson Mark L.Jun 9, 2025
Proposed Sale
$110.4425,000$2.8M
AXSM
Jacobson Mark L.May 28, 2025
Proposed Sale
$103.4520,000$2.1M
AXSM
Jacobson Mark L.May 27, 2025
Proposed Sale
$0.0020,673$1